LICENSE: This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.


2985190R
5004
J Neurochem
J. Neurochem.
Journal of neurochemistry
0022-3042
1471-4159

29315574
6371812
10.1111/jnc.14292
NIHMS933309
Article
Palmitate induced C/EBP homologous protein activation leads to NF-κB -mediated increase in BACE1 activity and Amyloid beta genesis
Marwarha Gurdeep
Schommer Jared
Lund Jonah
Schommer Trevor
Ghribi Othman *
Department of Biomedical Sciences, School of Medicine &amp; Health Sciences, University of North Dakota, Grand Forks, ND 58203
* Corresponding author: Dr. Othman Ghribi Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, 1301 North Columbia Road, Grand Forks, North Dakota, U.S.A. 58202, Phone: 701-777 2522; Fax: 701-777 4490, othman.ghribi@med.und.edu
DR. OTHMAN GHRIBI (Orcid ID : 0000-0002-4683-1286)

9 1 2018
14 2 2018
3 2018
01 3 2019
144 6 761779
This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.
The etiology of Alzheimer’s disease (AD) is egregiously comprehended, but epidemiological studies have posited that diets rich in the saturated fatty acid palmitic acid (palmitate) are a significant risk factor. The production and accumulation of Amyloid-beta peptide (Aβ) is considered the core pathological molecular event in the pathogenesis of AD. The rate limiting step in Aβ genesis from Amyloid-β precursor protein (AβPP) is catalyzed by the enzyme β-site APP cleaving enzyme 1 (BACE1), the expression and enzymatic activity of which is significantly upregulated in the AD brain. In this study, we determined the molecular mechanisms that potentially underlie the palmitate-induced up-regulation in BACE1 expression and augmented Aβ production. We demonstrate that a palmitate-enriched diet and exogenous palmitate treatment evoke an increase in BACE1 expression and activity leading to enhanced Aβ genesis in the mouse brain and SH-SY5Y-APPSwe cells respectively, through the activation of the transcription factor NF-κB. Chromatin Immunoprecipitation (ChIP) assays and luciferase reporter assays revealed that palmitate enhances BACE1 expression by increasing the binding of NF-κB in the BACE1 promoter followed by an enhancement in the transactivation of the BACE1 promoter. Elucidation and delineation of upstream molecular events unveiled a critical role of the endoplasmic reticulum (ER) stress-associated transcription factor, C/EBP Homologous Protein (CHOP) in the palmitate-induced NF-κB activation, as CHOP knock-down cells and Chop−/− mice do not exhibit the same degree of NF-κB activation in response to the palmitate challenge. Our study delineates a novel CHOP-NF-κB signaling pathway that mediates palmitate-induced up-regulation of BACE1 expression and Aβ genesis.

Graphical Abstract

The mechanisms that underlie the palmitate-enriched diet induced increase in Amyloid-beta (Aβ) burden in the brain and subsequent increase in the risk of Alzheimer’s disease are poorly comprehended. Herein, we show that palmitate-enriched diet causes C/EBP Homologous Protein (CHOP) activation resulting in an increase in NF-κB transcriptional activity mediated trans-activation of the β-site APP cleaving enzyme 1 (BACE1) promoter. The ensuing increase in BACE1 protein levels and BACE1 enzymatic activity results in a significant increase in Aβ genesis and augmentation in the neurodegenerative cascade inherent in Alzheimer’s disease.

Alzheimer’s disease
β-site APP cleaving enzyme 1
C/EBP Homologous Protein
Endoplasmic Reticulum stress
nuclear factor of kappa-light-polypeptide gene enhancer of activated B cells
Palmitic acid

Introduction

Alzheimer’s disease (AD) is the most common progressive neurodegenerative disorder in the elderly that is characterized by cognitive impairment as well as deficits in learning and memory and is the sixth leading cause of death in the United States. The pathological hallmarks of AD include the intracellular accumulation of aggregated hyperphosphorylated protein tau (τ) as neurofibrillary tangles (NFT) and the extracellular deposition of aggregated Amyloid-β (Aβ) peptide as neuritic senile plaques. Aβ peptide, either in the soluble monomeric and oligomeric form or in the fibrillar-aggregated form, is considered a central instigating factor in the pathogenesis of AD (Glenner &amp; Wong 1984, Masters et al. 1985). The membrane-bound aspartyl protease β-site APP cleaving enzyme 1 (BACE1, or β-secretase) catalyzes the rate-limiting step in Aβ genesis from the transmembrane protein, amyloid-β precursor protein (AβPP), in the amyloidogenic pathway (Vassar et al. 1999, Hussain et al. 1999). The levels of BACE1 protein as well as its enzymatic activity are significantly augmented in the AD brain (Fukumoto et al. 2002, Holsinger et al. 2002, Li et al. 2004, Yang et al. 2003). In the amyloidogenic pathway, BACE1 cleaves AβPP at the β-site (Met671 – Asp672) to generate carboxy terminal fragment β (CTFβ, or C99 fragment), which is subsequently cleaved by the γ-secretase complex to generate the Aβ peptide (Haass &amp; Selkoe 1993). Alternatively, in the non-amyloidogenic pathway, a distinct set of enzymes that functionally constitute the group, α-secretases, cleaves AβPP at the α-site (Lys687 – Leu688) to generate carboxy terminal fragment α (CTFα, or C83 fragment), which is subsequently cleaved by the γ-secretase complex to generate the p3 peptide, thereby precluding the genesis of the deleterious Aβ peptide (Haass &amp; Selkoe 1993). Although the etiology of AD is multifactorial and very poorly comprehended, it is posited that a dynamic interplay among genetic, environmental, and dietary factors plays a role in the etio-pathogenesis. Numerous epidemiological studies have suggested that a saturated fat-enriched diet increases risk for AD (Kalmijn 2000, Kalmijn et al. 1997, Morris et al. 2003, Parrott &amp; Greenwood 2007, Barnard et al. 2014). This has been corroborated and concurred by a multitude of laboratory research studies that have demonstrated that a saturated fat diet causes cognitive impairment as well as deficits in learning and memory in rodent models (Greenwood &amp; Winocur 1990, Winocur &amp; Greenwood 1999). Saturated fat diets increase the plasma levels of the saturated free fatty acids (sFFA), palmitic acid (palmitate) and stearic acid (stearate), which cross the blood-brain-barrier (BBB) (Dhopeshwarkar &amp; Mead 1973) and add to the burden of saturated fatty acid pool in the brain (Hamilton &amp; Brunaldi 2007, Rapoport 2001). Current research and studies from our laboratory have shown that palmitate-enriched diets cause an increase in BACE1 expression, tau phosphorylation and AD-like changes in primary cortical neurons (Patil et al. 2006, Liu et al. 2013a, Liu et al. 2013b, Patil et al. 2007) and human SH-SY5Y neuroblastoma cells as well as the mouse hippocampus (Marwarha et al. 2017e). Our recent studies have also shown that palmitate-induced endoplasmic reticulum (ER) stress (Marwarha et al. 2016) causes an increase in BACE1 expression and activity leading to increases in Aβ genesis that is contingent on the activation of C/EBP Homologous Protein (CHOP) (Marwarha et al. 2017e). However, the downstream molecular mediators and signaling cascades that lead to a transcriptional increase in BACE1 expression, enhancing BACE1 activity and Aβ genesis have not been elucidated yet. In this study, we delineated the mechanisms that are downstream of CHOP and mediate the palmitate-induced increase in BACE1 expression and activity as well as Aβ engenderment.

ER stress is widely implicated in numerous pathogenic mechanisms that are inherent in AD (Ghribi 2006, Endres &amp; Reinhardt 2013, Hotamisligil 2010, Marwarha &amp; Ghribi 2012a, Marwarha 2011b). Chronic persistent ER stress results in the increased expression of the transcription factor CHOP (also called growth arrest and DNA damage induced gene-153, GADD153 or DDIT3) (Bartlett et al. 1992, Wang et al. 1996, Zinszner et al. 1998). In addition to transcriptionally up-regulating the expression of a plethora of genes involved in ER stress response, increased expression of CHOP also enhances the signaling and transcriptional activity of Nuclear factor of kappa-light-polypeptide gene enhancer of activated B cells (NF-κB) (Marwarha et al. 2013, Park et al. 2010). It is well characterized that NF-κB signaling and transcriptional activity positively and directly regulates the transcription of BACE1 (Chen et al. 2012, Kaltschmidt et al. 1997, Marwarha &amp; Ghribi 2017a, Marwarha &amp; Ghribi 2017b). Our earlier studies have unveiled a novel CHOP/NF-κB signaling pathway in the regulation of BACE1 expression (Marwarha et al. 2013). However, the extent to which palmitate modulates these pathways to impinge on BACE1 expression and subsequent Aβ genesis is not well known. In this study, we determined the impact of palmitate-enriched diet and exogenous palmitate treatment, in the mouse brains and in neuroblastoma cells respectively, on the dynamics of CHOP/NF-κB signaling interplay and delineated the underlying role of this molecular interplay in the augmentation of BACE1 expression and Aβ genesis.

Methods

Materials

Human SH-SY5Y neuroblastoma cells were purchased from American Type Culture Collection (ATCC, Manassas, VA) (Resource Identifier ID - RRID:CVCL_0019). Human SH-SY5Y neuroblastoma cells stably expressing the AβPP Swedish KM670/671NL double mutation (SH-SY5Y-APPSwe) were cultured in DMEM : Ham’s F12 with Glutamax (1:1; v/v), 10% fetal bovine serum, and 1% antibiotic/antimycotic mix. Cells were maintained at 37°C in a saturated humidity atmosphere containing 95% air and 5% CO2. All cell culture reagents, with the exception of fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) and antibiotic/antimycotic mix (Sigma Aldrich, Saint Louis, MO) were purchased from Invitrogen (Carlsbad, CA). Palmitic acid (CAS 57-10-3, Catalog # sc-203175) and sc-514 (CAS 354812-17-2, Catalog # sc-205504) were purchased from Santa Cruz Biotechnology (Dallas, TX). The expression plasmid for overexpressing full length native CHOP (CHOP 6: mCHOP-WT-9E10-pcDNA1) was a gift from Dr. David Ron (Addgene plasmid # 21913). The expression plasmid for overexpressing IκBα (CMV IκB alpha) was a gift from Dr. Inder Verma (Addgene plasmid # 12333). The expression plasmid for ectopically expressing the constitutively dominant active (Flag-tagged) IKKβ mutant (IKK2 S177E/S181E) was a gift from Dr. Anjana Rao (Addgene plasmid # 11105) (Mercurio et al. 1997). The luciferase reporter constructs encoding the NF-κB response elements in the BACE1 promoter region were purchased from SwitchGear Genomics (Active Motif, La Jolla, CA). The human and mouse CHOP double-stranded siRNA (Silencer® Select Pre-Designed &amp; Validated siRNA) and their respective scrambled non-silencing control siRNA were purchased from ThermoFisher Scientific (Waltham, MA). The list of siRNA and their respective targets are enumerated in Table 1. CHOP shRNA (set of 5 different shRNA), IKKβ shRNA (set of 5 different shRNA), IκBα shRNA (set of 5 different shRNA), all encoded in pLKO.1 lentiviral vector were purchased from Open Biosystems (GE Dharmacon, Lafayette, CO) and their respective target sequences are enumerated in Table 2.

Cell Culture and Treatments

Transfected SH-SY5Y-APPSwe cells and sc-514 (NF-κB inhibitor) pretreated SH-SY5Y-APPSwe cells (20μM for 2 hours) were treated with different concentrations of BSA (bovine serum albumin)-conjugated palmitate as described previously (Marwarha et al. 2016, Marwarha et al. 2017e). Briefly, palmitate stock solution of 250mM was prepared in 100% ethanol. BSA (5mM) stock solution was prepared in MilliQ water (18MΩ). Both, the palmitate and BSA stock solutions were sterile filtered using a 0.2μm filter. The requisite amounts of palmitate and BSA were added to sterile serum-free medium to yield the designated terminal palmitic acid concentrations with the ratio of palmitate and BSA being 6:1. The respective media were incubated for 1.5 hours to conjugate the palmitic acid to the BSA. The cells were treated with the designated concentration of palmitic acid conjugated to BSA for 24 hours.

Mouse experiments

Mice harboring a homozygous targeting deletion mutation to the Ddit3 gene (Chop−/− mice) were procured from The Jackson Laboratory [B6.129S(Cg)-Ddit3tm2.1Dron/J, Stock # 005530] (Bar Harbor, ME) (Resource Identifier ID - RRID:IMSR_JAX:005530). The corresponding C57BL/6J control mice were also procured from The Jackson Laboratory (Stock # 000664) (Resource Identifier ID - RRID:IMSR_JAX:000664). The mice were housed in individually ventilated cages at an ambient room temperature (23–25°C) and ambient relative humidity ranging between 50–70%. The mice were maintained on 12:12 hour light:dark cycle and allowed access to food and water ad libitum. Mice were randomly assigned or segregated into the dietary regimen. The Chop−/− mice and their wild-type C57BL/6J mice (all males, nine months of age) counterparts (n=15), each bearing a definite and exlcusive “serial number” ascribed for identification purposes during the genotyping phases, were randomly assigned to the given dietary regimen by depicting the individual respective mouse numbers on respective pieces of paper that were collectively pooled, mixed, and entered into the drawing “pot” for assignment into the given dieatry cohorts. Two drawing pots containing thirty (30) mice each were generated, each belonging to the respective genotype (Chop−/− mice and their wild-type C57BL/6J mice counterparts). The respective mouse numbers were drawn from each pot and designated to the respective cohort on an “alternate assigned” basis, with the odd pickings from the “pot” (such as the first, third, fifth, seventh, and so on so forth) being assigned to the palmitate-enriched diet cohort (TD 110616, Harlan Teklad, 2.2% w/w palmitic acid), while the even pickings from the “pot” (such as the second, fourth, sixth, eighth and so on so forth) being assigned to the corresponding control diet cohort (TD 85172, Harlan Teklad, 0.8% w/w palmitic acid). The ensuing, randomly generated, four different experimental cohorts of nine-month old male mice (n=15 per group) were fed the respective diets for three (3) months. The sample size (n=15) was derived from subjecting data from a pilot experiment to statistical analysis that generated the expected mean and standard deviation. The statistical level of significance (α) was set at 0.05 and the power of the experiment or statistical power (β) was set at 0.8 or 80%. This statistical sampling analysis minimized the number of mice that constituted the experimental cohort. The diets were isocaloric in relation to each other and the respective composition of the diets is shown in Table 3. Food-intake was monitored for the span of 24 hours, once every two weeks. No changes in food intake were observed (Marwarha et al. 2017e). Body weights were measured every two weeks and reported in our previous study (Marwarha et al. 2017e). Necropsy was performed at twelve (12) months of age. All animal procedures were carried out in accordance with the U.S. Public Health Service Policy on the Humane Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at the University of North Dakota (Protocol 1506-3c). The study and the research paradigm was not pre-registered and experimental blinding was not used in any of the experimental paradigms and procedures.

Western Blot analysis

Whole cell, cytosolic and nuclear homogenates from cells as well as the mouse cortices and hippocampi were prepared as previously described (Marwarha et al. 2014a, Marwarha et al. 2017b, Marwarha et al. 2017c, Marwarha et al. 2010a, Marwarha et al. 2010b). Proteins (10–40μg) were resolved on SDS-PAGE gels followed by transfer to a polyvinylidene difluoride membrane (BioRad, Hercules, CA) and incubation with the monoclonal antibodies listed in Table 4. The origin, source, the dilutions of the respective antibodies used for this study is compiled in Table 4. β-actin was used as a gel loading control for whole cell and cytosolic homogenates, whereas Histone H3 was used as a gel loading control for nuclear homogenates. The blots were developed with enhanced chemiluminescence (ClarityTM Western ECL blotting substrate, Bio-Rad, Hercules, CA) and imaged using a LiCOR Odyssey Fc imaging system.

Caspase 3/7 activity assay

The enzymatic activities of caspase 3/7 were determined as a surrogate measure of extent of apoptotic activity using the “Caspase-Glo® 3/7 Assay System” kit from Promega (Catalog # G8090) (Madison, WI) following manufacturer’s instructions. Data was normalized to the intensity of the absorbance in BSA-treated cells (control) (set as unit value) and expressed as a fold-change of the control ± SD (six wells per one experiment from three separate experiments, n=3).

Apoptotic cell death

The effects of CHOP overexpression on apoptotic and necrotic cell death were determined using the “Annexin V Human ELISA Kit” from ThermoFisher Scientific (Catalog # BMS252) (Waltham, MA) following manufacturer’s instructions. Data was normalized to the intensity of the absorbance in BSA-treated empty-vector expressing native cells (set as unit value) and expressed as a fold-change of the control ± SD (six wells per one experiment from three separate experiments, n=3).

Cell viability assays

The effects of CHOP overexpression on cell proliferation was determined using the “CyQUANT® Cell Proliferation Assay Kit” from ThermoFisher Scientific (Catalog # C7026) (Waltham, MA) following manufacturer’s instructions. Data was normalized to the intensity of fluorescence in BSA-treated empty-vector expressing native cells (set as unit value) and expressed as a fold-change of the control ± SD (six wells per one experiment from three separate experiments, n=3).

Lactate Dehydrogenase (LDH) assay for cytotoxicity

The levels of LDH were measured as a surrogate measure of cytotoxic cell death in response to palmitate treatment using the “CytoTox 96® Non-Radioactive Cytotoxicity Assay” from Promega (Catalog # G1780) (Madison, WI) following manufacturer’s instructions. Data was normalized to the intensity of the absorbance of maximal LDH release from each respective technical and biological replicate and expressed as percent LDH release relative to maximal LDH release from each respective measurement (six wells per one experiment from three separate experiments, n=3).

Enzyme-linked immunosorbent assay (ELISA)

Aβ1-42 and Aβ1-40 levels in neuroblastoma cells were quantified in the conditioned media (secreted) and cellular homogenates (intracellular) using an ELISA immunoassay kit (Invitrogen, Carlsbad, CA) following the manufacturer’s protocol and as described earlier (Marwarha et al. 2014b, Marwarha et al. 2013, Marwarha et al. 2017e). Intracellular Aβ1-42 and Aβ1-40 levels in the cellular homogenates were normalized to total protein content in the samples (pg/mg protein). Treatments were performed in quadruplet, (n=4, four biological replicates with three technical replicates within each biological replicate). The secreted Aβ1-42 and Aβ1-40 levels measured in the culture medium are expressed in pg/mL of media. Aβ1-42 and Aβ1-40 levels in the mouse hippocampus were quantified using the same aforementioned ELISA immunoassay kit (Invitrogen, Carlsbad, CA). The mouse hippocampal tissue was subjected to a sequential extraction procedure (Rostagno &amp; Ghiso 2009) to generate the following sub-cellular fractions containing the respective Aβ species - TBS-soluble Aβ (water soluble Aβ), 2% SDS soluble Aβ (detergent soluble Aβ), and 70% formic acid soluble Aβ (TBS insoluble Aβ, detergent insoluble Aβ) that reflects the total Aβ pool. Aβ levels in the mouse hippocampus were normalized to total protein content in the samples (pg/mg protein).

Quantitative real time RT-PCR analysis

Total RNA was extracted from treated cells as well as from mouse cortices and hippocampi using the 5 prime “PerfectPure RNA tissue kit” (5 Prime, Inc., Gaithersburg, MD) following manufacturer’s instructions and as described previously (Marwarha et al. 2014a, Marwarha et al. 2011a, Marwarha et al. 2011b, Marwarha et al. 2017e, Marwarha 2011a, Marwarha et al. 2012). cDNA was obtained by reverse transcribing 1μg of extracted RNA using an iScript cDNA synthesis kit” (BioRad, Hercules, CA). cDNA was obtained by reverse transcribing 1μg of extracted RNA using an iScript cDNA synthesis kit” (BioRad, Hercules, CA). The quantitative Real-time RT-PCR was performed using TaqMan chemistry using “Assays-on-Demand” probes (ABI, Foster City, CA) for human BACE1 (BACE1 gene) (Hs01121195_m1) and mouse Bace1 (Bace1 gene) (Mm00478664_m1). The amplification was performed using the “StepOnePlus” PCR System (ABI, Foster City, CA). The expression of specific transcripts amplified was normalized to the expression of 18s rRNA. The data were quantified and expressed as fold-change compared to the control by using the ΔΔCT method.

FRET-based BACE1 activity assay

BACE1 activity in cellular and tissue homogenates was determined using a FRET-based kit from Sigma-Aldrich (St. Louis, MO, Catalog # CS0010) following manufacturer’s protocol and as described previously (Marwarha et al. 2017e, Marwarha et al. 2014b, Marwarha et al. 2009). The raw data expressing the BACE1 activity in terms of percentage of substrate cleaved in respective samples was further normalized and expressed as fold-change compared to control.

Chromatin Immunoprecipitation (ChIP) Analysis

ChIP analysis was performed to evaluate the extent of p65 binding to the NF-κB binding elements in the BACE1 promoter region using “SimpleChIPTM Enzymatic Chromatic IP kit” from Cell Signaling (Boston, MA) following manufacturer’s instructions and as described earlier (Marwarha et al. 2017b, Marwarha et al. 2017c, Marwarha et al. 2017a, Marwarha et al. 2017e). The relative abundance of the p65 antibody precipitated chromatin containing the NF-κB binding site in the BACE1 promoter region was determined by qPCR using sequence specific primers (Qiagen Inc. (Valencia, CA) (Table 5). The amplification was performed using the “StepOnePlus” PCR System (ABI, Foster City, CA). The fold enrichment of the bound p65 in the BACE1 promoter region was calculated using the ΔΔCT method which normalizes ChIP CT values of each sample to the % input and background. The data was further normalized and expressed as fold-change compared to control.

Luciferase Reporter assays

Constructs encoding NF-κB response element and human BACE1 promoter conjugated to the firefly luciferase gene were used in the study (Marwarha et al. 2014c). SH-SY5Y-APPSwe cells were plated in 96-well plates at a density of 2×104 cells/well. The cells were transfected when 80% confluent with 0.25 μg of reporter constructs. Respective non-inducible reporter constructs containing constitutively expressing Renilla luciferase were used as negative internal controls. Constitutively expressing GFP constructs were used as positive control to determine transfection efficiency. The dual-luciferase assay was performed using a “Dual-Luciferase Reporter Assay System” (Promega, Madison, WI). The luminescence recorded is expressed as Relative Luminescence Units (RLU) and normalized to per mg protein. Unit value was assigned to control and the magnitude of differences among the samples is expressed relative to the unit value of control cells.

Statistical analysis

The significance of differences among the samples was assessed by non-parametric Kruskal-Wallis One Way Analysis of Variance followed by Dunn’s post-hoc test. Statistical analysis was performed with GraphPad Prism 6. Quantitative data for all the assays are presented as mean values ± S.D (mean values ± standard deviation) with unit value assigned to control and the magnitude of differences among the samples being expressed relative to the unit value of control as fold-change. Quantitative data for ELISA analysis are presented as mean values ± S.D with absolute concentrations of Aβ1-42 reported. The significance level (α) was set at probability (p) value &lt;0.05 establishing a 95% confidence interval (CI) as a threshold of statistical differences among the respective samples.

Results

NF-κB activation and transcriptional activity is required for the palmitate-induced CHOP-mediated increase in BACE1 expression and subsequent engenderment of Aβ

We determined the effects of palmitate treatment on NF-κB activation in SH-SY5Y-APPSwe human neuroblastoma cells (cells that stably express the Swedish KM670/671NL double mutant AβPP) as well as the effects of palmitate-enriched diet on NF-κB activation in the mouse hippocampus. Our recent study showed that exogenous palmitate treatment, for 24 hours at 100μM terminal concentration, increases BACE1 expression in cultured SH-SY5Y-APPSwe cells (Marwarha et al. 2017e). We therefore used this experimental paradigm, exogenous palmitate at 100μM terminal concentration in the cell-culture medium for 24 hours, throughout this study. We determined the levels of phosphorylated IKKβ and IκBα in whole cell homogenates as well as the nuclear levels of p65 and p50 following treatment with palmitate, as a surrogate measure of NF-κB activation. Phosphorylation of IKKα/β and IκBα (Supplemantal Fig S1A, S1C) as well as the subsequent nuclear translocation of the p65 and p50 subunits of NF-κB was pronouncedly increased in palmitate-treated SH-SY5Y-APPSwe cells (Supplemental Fig S1B, S1D). As NF-κB plays a critical role and directly regulates the transcription of BACE1 (Kaltschmidt et al. 1997), we next determined the role of NF-κB in palmitate-induced increase in BACE1 expression, augmentation in Aβ genesis, and the preferential shunting of AβPP processing towards the amyloidogenic pathway. To this end, we inhibited NF-κB signaling and transcriptional activity by knocking down IKKβ using shRNA or by ectopically over-expressing IκBα in SH-SY5Y-APPSwe cells. We also adopted a chemical approach by using sc-514, an IKKβ-specific inhibitor (Baxter et al. 2004), to abrogate NF-κB signaling and transcriptional activity as shown previously (Marwarha et al. 2013). Palmitate-evoked increase in BACE1 protein levels (Fig 1A), BACE1 mRNA expression and BACE1 activity (Fig 1B), as well as amyloidogenic processing of AβPP (Fig 1A), in SH-SY5Y-APPSwe cells were significantly reduced with IKKβ knock-down, ectopic overexpression of IκBα or pretreatment with sc-514 (Fig 1A, 1B). Further corroborating the involvement of NF-κB transcriptional activity in the palmitate-induced up-regulation of BACE1 expression emanated from ChIP studies demonstrating that palmitate treatment caused an increased in binding of the p65 subunit of NF-κB to the κB-elements in the BACE1 promoter region (Fig 1C, inset I) as well as an increasing the NF-κB transcriptional activity (Fig 1C, Inset II). Furthermore, palmitate treatment also resulted in an increase in BACE1 promoter activity that is contingent on NF-κB transcriptional activity (Fig 1D). The palmitate-induced enhancement in the BACE1 promoter activity was significantly mitigated in SH-SY5Y-APPSwe cells with compromised NF-κB activation due to either IKKβ knock-down or ectopic overexpression of IκBα or pretreatment with sc-514 (Fig 1D), suggesting that NF-κB transcriptional activity is necessary for palmitate-induced increase in BACE1 promoter activity. We next determined intracellular and secreted Aβ1-42 as well as Aβ1-40 as a functional correlate of effects of palmitate mediated through NF-κB activation. Palmitate-induced increase in intracellular as well as secreted Aβ1-42 (Fig 2A, 2B) and Aβ1-40 (Fig 2C, 2D) was significantly blunted in SH-SY5Y-APPSwe cells with compromised NF-κB activation due to either IKKβ knock-down or ectopic overexpression of IκBα or pretreatment with sc-514 (Fig 2A–2D), suggesting that NF-κB transcriptional activity is necessary for palmitate-induced increase in Aβ genesis (Fig 2A–2D).

CHOP expression is necessary for the palmitate-induced increase in NF-κB activation and transcriptional activity

We have recently shown that exogenous palmitate treatment and palmitate-enriched diet cause ER stress and induce CHOP expression that leads to an increase in BACE1 expression, enhanced BACE1 activity, and augmentation of Aβ genesis in cultured SH-SY5Y-APPSwe cells and the mouse hippocampus respectively (Marwarha et al. 2017e). Knocking-down CHOP expression in SH-SY5Y-APPSwe cells significantly attenuates the palmitate-induced increase in BACE1 expression and Aβ genesis (Marwarha et al. 2017e). Furthermore, Chop−/− mice fed a palmitate-enriched diet do not exhibit the same increase in BACE1 expression and Aβ burden compared to the C57BL/6J wild-type mice fed a palmitate-enriched diet (Marwarha et al. 2017e). However, questions still abounded with regards to the molecular mechanism(s) by which CHOP may induce the aforementioned effects. Previous studies from our laboratory (Marwarha et al. 2013) and by others (Park et al. 2010, Willy et al. 2015) have cogently also shown that CHOP is required for ER stress-induced activation of NF-κB signaling and transcriptional activity. We next determined the role of CHOP in the palmitate-induced NF-κB-mediated increase in BACE1 expression and Aβ genesis. To this end, we determined the palmitate-induced NF-κB activation in a CHOP-deficient paradigm. Palmitate treatment did not evoke the phosphorylation of IKKβ and IκBα (Fig 3A) as well as the subsequent nuclear translocation of the p65 and p50 subunits to the same degree in CHOP knocked-down SH-SY5Y-APPSwe cells compared to the native SH-SY5Y-APPSwe cells (Fig 3B). Accordingly, the binding of the p65 subunit of NF-κB to the BACE1 promoter region, as determined by ChIP analysis, was significantly attenuated in palmitate-treated CHOP knocked-down SH-SY5Y-APPSwe cells relative to the palmitate-treated native SH-SY5Y-APPSwe cells (Fig 3C). Furthermore, dual-luciferase reporter assays showed a significant reduction in NF-κB driven-BACE1 promoter activity in palmitate-treated CHOP knocked-down SH-SY5Y-APPSwe cells compared to palmitate-treated native SH-SY5Y-APPSwe cells (Fig 3D). C57BL/6J wild-type mice fed a palmitate-enriched diet also exhibited pronounced NF-κB activation in the cortex and the hippocampus, as assessed by a significant increase in the phosphorylation of IKKβ and IκBα as well as the subsequent nuclear translocation of the p65 and p50 subunits (Fig 4A, 4B). However, Chop−/− mice fed a palmitate-enriched diet did not exhibit, to the same degree, the increase in NF-κB activation in the cortex (Fig 4A) and the hippocampus (Fig 4B) as evidenced by a lack in the commensurate increase of the phosphorylation of IKKβ and IκBα as well as the subsequent nuclear translocation of the p65 and p50 subunits to the same extent as found in the of C57BL/6J wild-type mice fed a palmitate-enriched diet (Fig 4A, 4B). Furthermore, the pronounced increase in the binding of the p65 subunit of NF-κB to the BACE1 promoter region, as determined by ChIP analysis, was significantly attenuated in the cortices (Fig 4C) and the hippocampi (Fig 4D) of Chop−/− mice fed a palmitate-enriched diet compared to their C57BL/6J wild-type littermates fed a palmitate-enriched diet (Fig 4C, 4D). This suggests that the palmitate-induced NF-κB activation and the subsequent increase in BACE1 expression is contingent to a significant degree on CHOP expression.

Palmitate-induced NF-κB activation-mediated increase in BACE1 expression and Aβ genesis is downstream of CHOP activation

Given that palmitate-induced CHOP and NF-κB activation underlies the mechanism by which palmitate causes an increase in BACE1 expression, BACE1 activity, and Aβ genesis in SH-SY5Y-APPSwe cells (Fig 1A–1D, Fig 2A–2D, and Fig 3A–3D), we next determined whether palmitate-induced upregulation in CHOP expression is upstream or downstream of palmitate-induced augmentation of NF-κB activity in the context of the increase of BACE1 expression. To this end, we first over-expressed CHOP in SH-SY5Y-APPSwe cells with compromised activation of NF-κB achieved with IKKβ knock-down or ectopic overexpression of IκBα. We found that CHOP overexpression resulted in an increase in basal as well as palmitate-induced augmentation of BACE1 protein levels (Fig 5A), BACE1 mRNA expression (Fig 5C) and BACE1 activity (Fig 5D), amyloidogenic processing of AβPP (Fig 4A), intracellular as well as secreted Aβ1-42 (Fig 6A, 6B) and Aβ1-40 levels (Fig 6C, 6D). However, CHOP overexpression in cells devoid of NF-κB-transcriptional activity, as a result of IKKβ knock-down or by ectopic over-expression of IκBα, caused no significant increase in BACE1 protein levels (Fig 5A), BACE1 mRNA expression (Fig 5C) and BACE1 activity (Fig 5D), amyloidogenic processing of AβPP (Fig 5A), intracellular as well as secreted Aβ1-42 (Fig 6A, 6B) and Aβ1-40 levels (Fig 6C, 6D), irrespective of the ectopic CHOP overexpression (Fig 4A–4F). This demonstrated that NF-κB signaling is both necessary for and downstream of ER stress-induced CHOP expression in the palmitate-induced upregulation of BACE1 expression (Fig 5A–5D) and Aβ genesis (Fig 6A–6D). We further extricated underlying cell death as a potential confounding factor in the effects observed in ectopic CHOP overexpressing cells, as an increase in CHOP expression and transcriptional activity is known to induce cell death (Zinszner et al. 1998). We did not observe any underlying changes in caspase 3/7 activity, apoptotic and necrotic cell death, as well as cell proliferation in the CHOP overexpressing cells (Supplemental Fig S2A–S2D). CHOP overexpression did not result in any changes in the enzymatic activity of the effector caspases 3/7, both in the control-treated as well as palmitate-treated cells (Supplemental Fig S2A). We also determined the extent of Annexin V bound to phosphatidylserine-exposing apoptotic cells as a surrogate marker of early apoptotic cell death (Vermes et al. 1995, Koopman et al. 1994). There were no changes in the abundance of Annexin V conjugates suggesting no early apoptotic events, in both the control-treated as well as palmitate-treated cells CHOP overexpressing cells (Supplemental Fig S2B). To further extricate any apoptotic or necrotic mediated cell death, we determined the extent of lactate dehydrogenease (LDH) release and accumulation in the conditioned medium of all experimental groups. We observed no significant changes in LDH release and accumulation in CHOP overexpressing cells (Supplemental Fig S2C). Furthermore, there were no changes in cell proliferation as a consequence of CHOP overexpression (Supplemental Fig S2D), thereby extricating underlying cell proliferation fluxes in the effects elicited by CHOP overexpression. Our data is in accordance with other studies that have unveiled a very intricate temporal kinetic profile of CHOP-induced cell death, suggesting that only chronic CHOP activation induces apoptotic cell death, but not acute CHOP activation (Han et al. 2013, McCullough et al. 2001).

We also performed the corollary experiment, which entailed knocking-down CHOP expression in SH-SY5Y-APPSwe while constitutively activating NF-κB signaling and transcriptional activity by ectopically expressing the dominant active IKKβ (IKKβ S177E) mutant or knocking-down IκB (Fig 7A–7D and Fig 8A–8D). This resulted in a pronounced increase in basal as well as palmitate-induced augmentation of BACE1 protein levels (Fig 7A), BACE1 mRNA expression (Fig 7C) and BACE1 activity (Fig 7D), amyloidogenic processing of AβPP (Fig 7A), intracellular as well as secreted Aβ1-42 (Fig 8A, 8B) and Aβ1-40 levels (Fig 8C, 8D), despite the knock-down of CHOP, corroborating that NF-κB signaling is indeed downstream of ER stress-induced CHOP expression and consequently a more proximal regulator of BACE1 expression (Fig 7A–7D) and Aβ genesis (Fig 8A–8D) than CHOP.

Discussion

Diets rich in saturated fats are widely implicated in cognitive disorders including dementia of the Alzheimer’s type and mild cognitive impairment (MCI) (Barnard et al. 2014). Numerous epidemiological studies have posited that saturated fat enriched diets increase the risk of develpoing AD (Barnard et al. 2014, Kalmijn 2000, Kalmijn et al. 1997, Morris et al. 2003, Parrott &amp; Greenwood 2007). A plethora of laboratory studies have also shown that a diet rich in saturated fat causes cognitive dysfunction as well as deficits in learning and memory in different murine models of cognitive function assessment (Greenwood &amp; Winocur 1990, Winocur &amp; Greenwood 1999). While there is extensive epidemiological evidence implicating saturated fat and palmitate-enriched diets in precipitating cognitive impairement, evoking deficits in learning and memory, the underlying molecular determinants that mediate the effects, especially in the etio-pathogenesis of AD are poorly characterized. Palmitate has been shown to increase de novo ceramide synthesis and expression of pro-inflammatory cytokines in primary astrocytes in culture that led to an increase in BACE1 expression in primary cortical neurons that were challenged with the conditioned medium from the palmitate-treated primary astrocytes (Liu et al. 2013a, Liu et al. 2013b, Patil et al. 2007, Patil et al. 2006, Liu &amp; Chan 2014). A wide spectrum of laboratory studies have demonstrated the effects of a high-fat diet (HFD) on BACE1 activity and Aβ burden in a multitude of rodent models of AD (Fitz et al. 2010, Ho et al. 2004, Julien et al. 2010, Maesako et al. 2012, Maesako et al. 2015, Refolo et al. 2000, Cao et al. 2007, Levin-Allerhand et al. 2002, Thirumangalakudi et al. 2008, Vandal et al. 2014, Wang et al. 2013). In these studies the dieatry composition varied significantly pertaining to the content of saturated fatty acids, mono and poly-unsaturated fatty acids, as well as total lipids. Morevoer, many studies utilized a dietary regimen that entailed the presence of high cholesterol (Fitz et al. 2010, Refolo et al. 2000, Levin-Allerhand et al. 2002, Thirumangalakudi et al. 2008, Wang et al. 2013) and high sucrose (Cao et al. 2007) concomitant with high fat in the context of the macromolecular composition. Furthermore the respective diets did not exhibit parity in caloric density, another confounding determinant as high caloric diets are associated with increased risk of AD (Luchsinger et al. 2002). High cholesterol diets have been shown to induce AD-like pathology (Puglielli et al. 2003, Sparks et al. 1994, Refolo et al. 2000, Shie et al. 2002, Ghribi 2008, Ghribi &amp; Marwarha 2010) as well as being associated with the pathogenesis of other diseases (Marwarha et al. 2017d). Therefore, the inference drawn from the aforementioned studies, in the context of enhanced Aβ burden in the brain as a consequence of diet, cannot exclusively be ascribed to the saturated fat content, but also to presence of other macromolecular variables that make-up the constitution of the respective diet. A recent study demonstrated that treatment with exogenous palmitate increases Aβ levels in SK-N-MC neuroblastoma cells by activating the GPR40/Akt/mTOR/HIF1α and the GPR40/Akt/NF-κB signaling pathways (Kim et al. 2017). However, no in vivo study todate has characterized the effects of a palmitate-enriched diet per se on the transcriptional regulation of BACE1 expression and Aβ genesis and charactrized the mechanisms. This current study is the first to demonstrate the effects of a palmitate-enriched diet, per-se, on the upstream signaling mechanisms and transcription factors that dictate BACE1 expression. We recently implicated ER stress induced enhanced expression of CHOP in the palmitate-enriched diet and exogenous palmitate treatment-induced increase in BACE1 activity and Aβ engenderment (Ghribi &amp; Marwarha 2017) as well as tau phosphorylation (Marwarha &amp; Ghribi 2017d) in the mouse hippocampus and SH-SY5Y-APPSwe cells. We have previously shown that BACE1 expression is not increased to the same commensurate degree in the cortex and hippocampi of Chop−/− mice (twelve months) fed a palmitate-enriched diet (three months) compared to the age-matched C57BL/6J wild-type mice fed a palmitate-enriched diet (Marwarha et al. 2017e). Furthermore, the palmitate-enriched diet induced increase in total BACE1 activity in the cortex and hippocampi of C57BL/6J wild-type mice was significantly blunted in the Chop−/− mice fed a palmitate-enriched diet (Marwarha et al. 2017e). In this study we demomstrate that NF-κB activation mediates the palmitate-induced increase in BACE1 expression and activity that leads to enhanced Aβ genesis. We further demonstrate that the palmitate-induced CHOP activation-mediated enhanced BACE1 expression and the palmitate-induced NF-κB activation-mediated enhanced BACE1 expression are not two independent, disparate molecular events. Instead, the two are part of the same linear signaling pathway evoked by palmitate, and that ER stess-induced CHOP activation by palmitate is upstream of palmitate-induced NF-κB activation. The role of NF-κB in the neurodegenerative mechanims involved in the etio-pathogenesis of AD have been the substrate of numerous studies and reviews (Marwarha &amp; Ghribi 2017a, Snow &amp; Albensi 2016, Srinivasan &amp; Lahiri 2015, Mattson &amp; Meffert 2006, Marwarha &amp; Ghribi 2017c). Multiple lines of evidence have demonstrated increased NF-κB signaling and transcriptional activity in the AD brain (Boissiere et al. 1997, Kaltschmidt et al. 1997). Saturated fat enriched diets resulting in higher levels of sFFA, palmitate and stearate, in the plasma are known to cause increase NF-κB activation in peripheral tissues (Van Beek et al. 2012, Kennedy et al. 2009, Estadella et al. 2013). In this study, we demonstrate that palmitate-enriched diet evokes NF-κB activation in the mouse hippocampus and subsequently increases the NF-κB-mediated transactivation of the BACE1 promoter. We further show that the inhibition of NF-κB signaling and transcriptional activity significantly attenuates the palmitate-induced augmentation in BACE1 expression and Aβ genesis in cultured human SH-SY5Y neuroblastoma cells. The transcriptional regulation of BACE1 by NF-κB transcriptional activity has been very well characterized (Bourne et al. 2007, Chen et al. 2012, Buggia-Prevot et al. 2008, Marwarha &amp; Ghribi 2012b, Marwarha et al. 2014c, Marwarha et al. 2013, Marwarha et al. 2014b, Marwarha 2011a, Marwarha &amp; Ghribi 2017b). There is also extensive evidence that NF-κB signaling and transcriptional activity regulates Aβ production either thorugh the regulation of BACE1 activity or independent of BACE1 activity (Tomita et al. 2000, Pandey et al. 2009, Paris et al. 2007, Chami et al. 2012, Kim et al. 2017). A few studies have shown that NF-κB trancriptional activity represses BACE1 promoter activity and BACE1 expression (Bourne et al. 2007). This duality in BACE1 promoter modulation by NF-κB could be attributed to the molecular composition of the NF-κB heterodimer. BACE1 promoter is transactivated by the p65/p50 and p65/p52 NF-κB heterodimers, while the binding of c-Rel/p52 NF-κB heterodimers transrepresses the BACE1 promoter (Bourne et al. 2007). Our study is the first to demonstrate that a palmitate-enriched diet increases BACE1 expression and Aβ burden in the mouse hippocampus by increasing NF-κB-mediated transactivation of the BACE1 promoter. We further show that this palmitate-induced NF-κB transctivation of the BACE1 promoter is significantly contingent on palmitate-induced CHOP expression which is upstream of NF-κB activation. Future studies delving into the molecular entities and mediators that link the activation of CHOP to NF-κB activation are being designed and tested by our group. Furthermore, the involvemnt of palmitate-induced NF-κB activation in the pathogenesis of other neurodegenerative disorders needs to be explored as well (Marwarha &amp; Ghribi 2015). The effects of exogenous palmitate treatment in cells and palmitate-enriched diet on γ-secretase activity or on the expression of individual respective components of the γ-secretase complex was not determined in this study. It is conceivable that palmitate-induced increase in Aβ genesis could be a composite of both, increase BACE1 enzymatic activity as well as γ-secretase enzymatic activity. This study focused on the palmitate-induced transcriptional up-regulation of BACE1 and unveiled a novel palmitate-induced cross-talk between CHOP and NF-κB signaling that underlies BACE1 regulation at the transcriptional level. Our study delineates and elucidates a novel signaling cascade, CHOP/NF-κB signaling pathway in mediating the palmitate-induced upregulation in BACE1 expression and Aβ genesis. Further studies are warranted to determine the role of this pathway in the palmitate-induced cognitive impairment as well as learning and memory deficits.

It is known that BACE1 apportionment into different sub-cellular compartments is the primary determinant of Aβ genesis (Cole &amp; Vassar 2007, Zhang &amp; Song 2013). Our current studies are determining the effects of palmitate on BACE1 levels and specific BACE1 enzymatic activity in different cellular fractions – Endoplasmic Reticulum (ER) membrane, trans Golgi Network (TGN), endosomes, and plasma membrane. Furthermore, BACE1 is localized into distinct subcellular micro-domains within neurons, primarily in the dendrites and the axons (Laird et al. 2005, Goldsbury et al. 2006) and undergoes unidirectional endosomal-mediated anterograde transport, concomitant with AβPP, along the axonal axis toward the presynaptic terminals (Laird et al. 2005, Goldsbury et al. 2006, Zhao et al. 2007, Sannerud et al. 2011, Thinakaran &amp; Koo 2008). It is largely the consensus, the neuronal Aβ is engendered within this endocytic compartment during the anterograde transport along the axonal axis (Harris et al. 2010, Lazarov et al. 2002, Sheng et al. 2002, Cirrito et al. 2005, Sokolow et al. 2012). Characterizing this axonal pool of BACE1 is of seminal relevance in AD, as an increase in BACE1 accumulation is observed in the brains of AD patients as well as brains of 5xFAD and Tg2576 mice (Zhao et al. 2007, Kandalepas et al. 2013). Our future studies are aimed at determining and dissecting the effects of palmitate on this endocytic compartmentalization and axonal trafficking of BACE1. BACE1 is extensively localized in the presynaptic terminals (Zhao et al. 2007) where it plays an indispensable role in synaptic transmission impinging on physiological and behavioral correlates of learning and memory as well as cognitive function (Yan &amp; Vassar 2014). Current on-going studies by our group are determining the effects of palmitate-enriched diets on surrogate correlates of behavior as well as cognitive function and substantiating the putative role of CHOP/NF-κB signaling cross-talk elicited fluxes in BACE1 targeting that could underlie the behavioral and cognitive deficits evoked by palmitate-enriched diets.

Supplementary Material

Supp FigS1-2

This work was supported by a Grant from the NIH (R01AG045264) to Dr. Othman Ghribi.

List of Abbreviations

Aβ Amyloid beta

AβPP Amyloid beta precursor protein

AD Alzheimer’s disease

BACE1 β-site APP cleaving enzyme 1

CHOP C/EBP Homologous Protein

ChIP Chromatin Immunoprecipitation

CTFα carboxy terminal fragment α

CTFβ carboxy terminal fragment β

ER Endoplasmic Reticulum

GPR40 G-protein-coupled receptor 40

HIF1α Hypoxia-inducible factor 1-alpha

IκBα Inhibitor of Nuclear factor of kappa-light-polypeptide gene enhancer of activated B cells, alpha

IKKβ Inhibitor of Kappa-light-polypeptide gene enhancer of activated B-Cells, kinase beta

LDH lactate dehydrogenase

mTOR mammalian Target of Rapamycin

NF-κB Nuclear factor of kappa-light-polypeptide gene enhancer of activated B cells

NFT Neurofibrillary tangles

PA palmitic acid

sAPPα soluble Amyloid beta precursor protein α

sAPPβ soluble Amyloid beta precursor protein β

sFFA saturated free fatty acids

Figure 1 Palmitate-induced increase in BACE1 expression levels and enzymatic activity is contingent on NF-κB activation

(A) Representative western blots show that inhibition of NF-κB activation, either by pretreatment (for 3 hours) of the cells with sc-514, a IKKβ-specific inhibitor, or by knocking-down IKKβ expression using shRNA, or by ectopic overexpression of IκBα, significantly attenuates the exogenous palmitate treatment (100μM for 24 hours) - induced increase in BACE1 protein levels accompanied by a decrease in the amyloidogenic processing of AβPP as evidenced by a decrease in the palmitate-induced increase in sAPPβ and CTFβ levels concomitant with an increase in the palmitate-induced decrease in sAPPα and CTFα levels in the whole cell homogenates from SH-SY5Y-APPSwe cells. (B) Inhibition of NF-κB activation attenuates the palmitate-induced increase in BACE1 mRNA expression and BACE1 activity in SH-SY5Y-APPSwe cells. (C) ChIP analysis (Inset I) and Dual luciferase reporter assay (Inset II) show that exogenous palmitate treatment increases the binding of the p65 subunit of NF-κB to the BACE1 promoter region and the NF-κB transcriptional activity, respectively, in SH-SY5Y-APPSwe cells. (D) Dual luciferase reporter assays show that exogenous palmitate treatment increases the transactivation of the BACE1 promoter that is contingent on NF-κB transcriptional activity. Data is expressed as Mean ± S.D and includes determination made in four (n=4) separate cell culture experiments. *p &lt; 0.05, ***p &lt; 0.001 versus BSA-treated control cells or BSA-treated GFP knock-down cells or BSA-treated pCMV-EV transfected cells; ††p &lt; 0.01, versus palmitate-treated control cells or palmitate-treated GFP knock-down cells or palmitate-treated pCMV-EV transfected cells.

PA= palmitic acid

Figure 2 Palmitate induced increase in Aβ genesis is dependent on NF-κB activation

(A–D) ELISA immunoassays show that inhibition of NF-κB activation significantly attenuates the exogenous palmitate treatment-induced increase in the levels of the (A) intracellular Aβ1-42 species, (B) secreted Aβ1-42 species, (C) intracellular Aβ1-40 species, and (D) secreted Aβ1-40 species, in the whole cell lysates and the conditioned media from SH-SY5Y-APPSwe cells. Data is expressed as Mean ± S.D and includes determination made in four (n=4) separate cell culture experiments. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001 versus BSA-treated control cells or BSA-treated GFP knock-down cells or BSA-treated pCMV-EV transfected cells; ††p &lt; 0.01, versus palmitate-treated control cells or palmitate-treated GFP knock-down cells or palmitate-treated pCMV-EV transfected cells.

PA= palmitic acid

Figure 3 Palmitate-induced NF-κB transcriptional activation and the subsequent augmentation in BACE1 expression is contingent to a significant degree on CHOP expression

(A, B) Representative western blots show that knocking-down CHOP expression using a RNAi approach significantly attenuates the palmitate-induced increase in NF-κB activation as evidenced by a pronounced decrease in the palmitate-induced increase in phosphorylation of IKKβ and IκBα (A) followed by a significant reduction in the palmitate-induced increase in the nuclear translocation of the p65 and p50 subunits of NF-κB (B) in SH-SY5Y-APPSwe cells. (C) ChIP analysis shows that knocking-down CHOP expression attenuates the palmitate-induced increase in the p65 NF-κB binding to the proximal BACE1 promoter in SH-SY5Y-APPSwe cells. (D) Luciferase reporter assays demonstrate that knocking-down CHOP expression significantly mitigates the exogenous palmitate treatment-induced increase in NF-κB driven BACE1 promoter transactivation in SH-SY5Y-APPSwe cells. Data is expressed as Mean ± S.D and includes determination made in four (n=4) separate cell culture experiments. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001 versus BSA-treated GFP knock-down cells or BSA-treated scrambled siRNA transfected cells; ††p &lt; 0.01, versus palmitate-treated GFP knock-down cells or palmitate-treated scrambled siRNA transfected cells.

PA= palmitic acid

Figure 4 Chop−/− mice do not exhibit the palmitate-enriched diet-induced increase in NF-κB activation as well as binding of p65 NF-κB in the proximal BACE1 promoter

(A, B) Representative western blots show that Chop−/− mice fed a palmitate-enriched diet do not exhibit, to the same degree, the increase in NF-κB activation as evidenced by the lack of a pronounced increase in the phosphorylation of IKKβ and IκBα thereby precluding the subsequent increase in the nuclear translocation of the p65 and p50 subunits of NF-κB, in the cortex (A) and the hippocampus (B), compared to the C57BL/6J wild-type mice fed a palmitate-enriched diet. (C, D) ChIP analysis shows that Chop−/− mice fed a palmitate-enriched diet have significantly lower levels of p65 NF-κB bound to the proximal BACE1 promoter in the cortex (C) and the hippocampus (D), compared to the C57BL/6J wild-type mice fed a palmitate-enriched diet. Data is expressed as Mean ± S.D and includes determination made in six (n=6) different animals from each group. ***p &lt; 0.001, versus C57BL/6J wild-type mice fed a control chow diet; ††p &lt; 0.01, versus C57BL/6J wild-type mice fed a palmitate-enriched diet; △p &lt; 0.05, △△p &lt; 0.01 versus Chop−/− mice fed a control chow diet.

PA= palmitic acid

Figure 5 CHOP overexpression-induced BACE1 expression is abrogated in cells lacking NF-κB activity

(A, B) Representative western blots show that CHOP ectopic overexpression-induced increase in BACE1 protein levels and amyloidogenic processing of AβPP is abrogated in cells with compromised NF-κB activation achieved as a result of knocking-down IKKβ expression or ectopic overexpression of IκBα, in SH-SY5Y-APPSwe cells. (C, D) Inhibition of NF-κB activation, as a result of knocking-down IKKβ expression or ectopic overexpression of IκBα, also abrogates the CHOP ectopic overexpression-induced increase in BACE1 mRNA expression (C) and BACE1 activity (D) in SH-SY5Y-APPSwe cells. Data is expressed as Mean ± S.D and includes determination made in four (n=4) separate cell culture experiments. △△p &lt; 0.01, versus BSA-treated GFP shRNA transfected CHOP overexpressing cells; ●●●p&lt;0.001 versus palmitate-treated GFP shRNA transfected CHOP overexpressing cells; ◆◆p&lt;0.01, ◆◆◆p&lt;0.001 versus BSA-treated pCMV-EV transfected CHOP overexpressing cells; ■■p&lt;0.01, versus palmitate-treated pCMV-EV transfected CHOP overexpressing cells.

PA= palmitic acid

Figure 6 CHOP overexpression-induced Aβ genesis is attenuated in cells lacking NF-κB activity

(A–D) ELISA immunoassays show that inhibition of NF-κB activation abrogates the CHOP ectopic overexpression-induced increase in the levels of the (A) intracellular Aβ1-42 species, (B) secreted Aβ1-42 species, (C) intracellular Aβ1-40 species, and (D) secreted Aβ1-40 species, in the whole cell lysates and the conditioned media from SH-SY5Y-APPSwe cells. Data is expressed as Mean ± S.D and includes determination made in four (n=4) separate cell culture experiments. △p &lt; 0.05, △△p &lt; 0.01, versus BSA-treated GFP shRNA transfected CHOP overexpressing cells; ●●p&lt;0.01 versus palmitate-treated GFP shRNA transfected CHOP overexpressing cells; ◆p&lt;0.05, ◆◆p&lt;0.01, versus BSA-treated pCMV-EV transfected CHOP overexpressing cells; ■■p&lt;0.01, versus palmitate-treated pCMV-EV transfected CHOP overexpressing cells.

PA= palmitic acid

Figure 7 Constitutive activation of NF-κB induces BACE1 expression despite the knock-down of CHOP expression

(A, B) Representative western blots show that the CHOP knock down-induced mitigation in BACE1 protein levels and amyloidogenic processing of AβPP is completely lost in cells with constitutive NF-κB activation achieved as a result of knocking-down IκBα expression or by ectopic overexpression of constitutive dominant active IKKβ mutant (IKKβ S177E), in SH-SY5Y-APPSwe cells. (C, D) Constitutive activation of NF-κB, as a result of knocking-down IκBα expression or ectopic overexpression of constitutive dominant active IKKβ mutant (IKKβ S177E), also completely reverses the CHOP knock down-induced decrease in BACE1 mRNA expression (C) and BACE1 activity (D) in SH-SY5Y-APPSwe cells. (E, F) ELISA immunoassays show that constitutive NF-κB activation, completely reverses the CHOP knocked-down - induced decrease in the levels of the intracellular Aβ1-42 species in the whole cell lysates (E) and secreted Aβ1-42 species in the conditioned media (F), from SH-SY5Y-APPSwe cells. Data is expressed as Mean ± S.D and includes determination made in four (n=4) separate cell culture experiments. △△p &lt; 0.01, versus BSA-treated pCMV2-EV transfected CHOP knocked-down cells; ●●●p&lt;0.001, versus palmitate-treated pCMV2-EV transfected CHOP knocked-down cells; ◆◆p&lt;0.01, versus BSA-treated GFP shRNA transfected CHOP knocked-down cells; ■■■p&lt;0.001, versus palmitate-treated GFP shRNA transfected CHOP knocked-down cells.

PA= palmitic acid

Figure 8 Constitutive activation of NF-κB increases Aβ genesis despite the knock-down of CHOP expression

(A–D) ELISA immunoassays show that constitutive NF-κB activation, completely reverses the CHOP knocked-down - induced decrease in the (A) intracellular Aβ1-42 species, (B) secreted Aβ1-42 species, (C) intracellular Aβ1-40 species, and (D) secreted Aβ1-40 species, in the whole cell lysates and the conditioned media from SH-SY5Y-APPSwe cells. Data is expressed as Mean ± S.D and includes determination made in four (n=4) separate cell culture experiments. △△p &lt; 0.01, versus BSA-treated pCMV2-EV transfected CHOP knocked-down cells; ●●p&lt;0.01, ●●●p&lt;0.001, versus palmitate-treated pCMV2-EV transfected CHOP knocked-down cells; ◆◆p&lt;0.01, versus BSA-treated GFP shRNA transfected CHOP knocked-down cells; ■■p&lt;0.01, ■■■p&lt;0.001, versus palmitate-treated GFP shRNA transfected CHOP knocked-down cells.

PA= palmitic acid

Table 1 List of siRNA and their target sequences used for RNA interference

Species	Gene ID	mRNA target	RNA interference	RefSeq	siRNA location	
Human	1649	DDIT3 (CHOP)	siRNA	NM_001195053	817	
Human	1649	DDIT3 (CHOP)	siRNA	NM_001195054	764	
Human	1649	DDIT3 (CHOP)	siRNA	NM_001195055	741	
Human	1649	DDIT3 (CHOP)	siRNA	NM_001195056	927	
Human	1649	DDIT3 (CHOP)	siRNA	NM_001195057	646	
Human	1649	DDIT3 (CHOP)	siRNA	NM_004083	660	

Table 2 List of shRNA target sequences used for RNA interference

Species	Gene ID	mRNA target	RNA interference	Sequence	
Human	1649	DDIT3 (CHOP)	shRNA	ATTGAGGGTCACATCATTGGC	
Human	1649	DDIT3 (CHOP)	shRNA	TTCTTCCTCTTCATTTCCAGG	
Human	1649	DDIT3 (CHOP)	shRNA	TTGGTGCAGATTCACCATTCG	
Human	1649	DDIT3 (CHOP)	shRNA	TTCCAGGAGGTGAAACATAGG	
Human	1649	DDIT3 (CHOP)	shRNA	TTTCCTTTCATTCTCCTGTTC	
Human	3551	IKBKB (IKKβ)	shRNA	TTTCAGATACTTTCCCAGTGC	
Human	3551	IKBKB (IKKβ)	shRNA	TTCTTCACTCTTCTTGGCTGG	
Human	3551	IKBKB (IKKβ)	shRNA	ATGTTCAAGATATGAACCAGC	
Human	3551	IKBKB (IKKβ)	shRNA	AAACTGGTTCAGGTACTTCCG	
Human	3551	IKBKB (IKKβ)	shRNA	TTCGGAGGAGATTCATCATGG	
Human	4792	NFKBIA (IκBα)	shRNA	AATTTCTGGCTGGTTGGTGAT	
Human	4792	NFKBIA (IκBα)	shRNA	AAGTGGAGTGGAGTCTGCTGC	
Human	4792	NFKBIA (IκBα)	shRNA	TTCAGGATGGAGTGGAGGTGC	
Human	4792	NFKBIA (IκBα)	shRNA	ATTTCAATGATCTTTCTCGTC	
Human	4792	NFKBIA (IκBα)	shRNA	AACTCCGTGAACTCTGACTCT	

Table 3 Composition of the control chow diet and palmitate-enriched diet

	Control chow diet
NIH07 open formula rodent diet – original - 0.8 % palmitic acid	palmitate-enriched diet
NIH07 open formula rodent diet – palmitate enriched – 2.2 % palmitic acid	
Protein	23.60 % w/w	23.60 % w/w	
Carbohydrates	65.80 % w/w	65.80 % w/w	
Total Fat	5.60 % w/w	5.60 % w/w	
Total Energy	4.08 Kcal/gram	4.08 Kcal/gram	
Myristic acid (14:0)	0.10 % w/w	0.10 % w/w	
Palmitic acid (16:0)	0.80 % w/w	2.20 % w/w	
Stearic acid (18:0)	0.20 % w/w	0.20 % w/w	
Palmitoleic acid (16:1)	trace	trace	
Oleic acid (18:1)	1.20 % w/w	1.20 % w/w	
Gadoleic acid (20:1)	trace	trace	
Linoleic acid (18:2 n6)	2.20 % w/w	0.80 % w/w	
Linolenic acid (18:3 n3)	0.20 % w/w	0.20 % w/w	
Arachadonic acid (20:4 n6)	trace	trace	
EPA (20:5 n3)	0.10 % w/w	0.10 % w/w	
DHA (22:6 n3)	0.30 % w/w	0.30 % w/w	

Table 4 List of monoclonal and polyclonal antibodies used in the study

Antibody	Dilution	Amount	Host	Manufacturer	Catalog #	Resource Identifier ID (RRID)	
β-Actin	1:2500	2 μg	mouse	Santa Cruz BioTechnology	sc-47778 (C4)	AB_626632	
BACE1	1:1000	5 μg	rabbit	EMD Millipore	AB5832	AB_2258785	
CHOP	1:500	10 μg	rabbit	Cell Signaling Technology	5554 (D46F1)	AB_10694399	
CTFα/ CTFβ	1:400	12.5 μg	rabbit	BioLegend	825001	AB_2564886	
Histone H3	1:1000	5 μg	rabbit	Santa Cruz BioTechnology	sc-8654 (C16)	AB_2118303	
p-Ser32/36 IκBα	1:250	20 μg	mouse	Cell Signaling Technology	9246 (5A5)	AB_2267145	
IκBα	1:1000	5 μg	rabbit	Cell Signaling Technology	9242	AB_823540	
p-Ser176/180 IKKα/β	1:250	20 μg	rabbit	Cell Signaling Technology	2697 (16A6)	AB_2291699	
IKKβ	1:500	10 μg	rabbit	Cell Signaling Technology	2678 (L570)	AB_10829159	
p50	1:1000	5 μg	rabbit	Cell Signaling Technology	3035	AB_330564	
p65	1:1000	5 μg	rabbit	Cell Signaling Technology	4764 (C22B4)	AB_10831827	
sAPPα	1:500	10 μg	rabbit	BioLegend	813501	AB_2564770	
sAPPβ	1:500	10 μg	rabbit	BioLegend	813401	AB_2564769	

Table 5 List of primers used for ChIP analysis

Species	Gene	Gene ID	Primer pair	Reference Sequence	Primers	
Human	BACE1	23621	Forward	NT_033899.9	5′- ATTGTGTGGAACCCCACTGC - 3′ (Chen et al. 2012)	
Human	BACE1	23621	Reverse	NT_033899.9	5′- GCAGTGGGGTTCCACACAAT - 3′ (Chen et al. 2012)	
Mouse	Bace1	23821	Forward	NT_039472.8	5′- GAGAGCCCCTCAGCTTCTTT-3′ (Wang et al. 2015)	
Mouse	Bace1	23821	Reverse	NT_039472.8	5′- GGGGCCCTGATAGCTTAAAA-3 (Wang et al. 2015)	

conflict of interest disclosure

The authors declare that they have no competing interests.


Barnard ND Bunner AE Agarwal U 2014 Saturated and trans fats and dementia: a systematic review Neurobiol Aging 35 Suppl 2 S65 73 24916582
Bartlett JD Luethy JD Carlson SG Sollott SJ Holbrook NJ 1992 Calcium ionophore A23187 induces expression of the growth arrest and DNA damage inducible CCAAT/enhancer-binding protein (C/EBP)-related gene, gadd153. Ca2+ increases transcriptional activity and mRNA stability J Biol Chem 267 20465 20470 1400365
Baxter A Brough S Cooper A 2004 Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors Bioorg Med Chem Lett 14 2817 2822 15125939
Boissiere F Hunot S Faucheux B Duyckaerts C Hauw JJ Agid Y Hirsch EC 1997 Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer’s disease Neuroreport 8 2849 2852 9376517
Bourne KZ Ferrari DC Lange-Dohna C Rossner S Wood TG Perez-Polo JR 2007 Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides J Neurosci Res 85 1194 1204 17385716
Buggia-Prevot V Sevalle J Rossner S Checler F 2008 NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42 J Biol Chem 283 10037 10047 18263584
Cao D Lu H Lewis TL Li L 2007 Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease J Biol Chem 282 36275 36282 17942401
Chami L Buggia-Prevot V Duplan E Delprete D Chami M Peyron JF Checler F 2012 Nuclear factor-kappaB regulates betaAPP and beta- and gamma-secretases differently at physiological and supraphysiological Abeta concentrations J Biol Chem 287 24573 24584 22654105
Chen CH Zhou W Liu S Deng Y Cai F Tone M Tone Y Tong Y Song W 2012 Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer’s disease Int J Neuropsychopharmacol 15 77 90 21329555
Cirrito JR Yamada KA Finn MB 2005 Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo Neuron 48 913 922 16364896
Cole SL Vassar R 2007 The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer’s Disease Current Genomics 8 509 530 19415126
Dhopeshwarkar GA Mead JF 1973 Uptake and transport of fatty acids into the brain and the role of the blood-brain barrier system Adv Lipid Res 11 109 142 4608446
Endres K Reinhardt S 2013 ER-stress in Alzheimer’s disease: turning the scale? Am J Neurodegener Dis 2 247 265 24319643
Estadella D da Penha Oller do Nascimento CM Oyama LM Ribeiro EB Damaso AR de Piano A 2013 Lipotoxicity: effects of dietary saturated and transfatty acids Mediators Inflamm 2013 137579 23509418
Fitz NF Cronican A Pham T Fogg A Fauq AH Chapman R Lefterov I Koldamova R 2010 Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice J Neurosci 30 6862 6872 20484628
Fukumoto H Cheung BS Hyman BT Irizarry MC 2002 Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease Arch Neurol 59 1381 1389 12223024
Ghribi O 2006 The role of the endoplasmic reticulum in the accumulation of beta-amyloid peptide in Alzheimer’s disease Curr Mol Med 6 119 133 16472119
Ghribi O 2008 Potential mechanisms linking cholesterol to Alzheimer’s disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle J Alzheimers Dis 15 673 684 19096164
Ghribi O Marwarha G 2010 Cholesterol causes Alzheimer pathology through Akt/mTOR inhibition Alzheimer’s &amp; Dementia: The Journal of the Alzheimer’s Association 6 S402 S403
Ghribi O Marwarha G 2017 PALMITATE INDUCES BACE1 EXPRESSION AND ACTIVITY BY INDUCING STEROL RESPONSE ELEMENT BINDING PROTEIN 1 EXPRESSION AND ACTIVATION IN THE MOUSE HIPPOCAMPUS AND HUMAN SH-SY5Y NEUROBLASTOMA CELLS Alzheimer’s &amp; Dementia: The Journal of the Alzheimer’s Association 13 P656 P657
Glenner GG Wong CW 1984 Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem Biophys Res Commun 120 885 890 6375662
Goldsbury C Mocanu MM Thies E Kaether C Haass C Keller P Biernat J Mandelkow E Mandelkow EM 2006 Inhibition of APP Trafficking by Tau Protein Does Not Increase the Generation of Amyloid-β Peptides Traffic 7 873 888 16734669
Greenwood CE Winocur G 1990 Learning and memory impairment in rats fed a high saturated fat diet Behav Neural Biol 53 74 87 2302144
Haass C Selkoe DJ 1993 Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide Cell 75 1039 1042 8261505
Hamilton JA Brunaldi K 2007 A model for fatty acid transport into the brain J Mol Neurosci 33 12 17 17901540
Han J Back SH Hur J 2013 ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death Nat Cell Biol 15 481 490 23624402
Harris JA Devidze N Verret L 2010 Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network Neuron 68 428 441 21040845
Ho L Qin W Pompl PN 2004 Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease FASEB J 18 902 904 15033922
Holsinger RM McLean CA Beyreuther K Masters CL Evin G 2002 Increased expression of the amyloid precursor beta-secretase in Alzheimer’s disease Ann Neurol 51 783 786 12112088
Hotamisligil GS 2010 Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Cell 140 900 917 20303879
Hussain I Powell D Howlett DR 1999 Identification of a novel aspartic protease (Asp 2) as beta-secretase Mol Cell Neurosci 14 419 427 10656250
Julien C Tremblay C Phivilay A Berthiaume L Emond V Julien P Calon F 2010 High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model Neurobiol Aging 31 1516 1531 18926603
Kalmijn S 2000 Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies J Nutr Health Aging 4 202 207 11115801
Kalmijn S Launer LJ Ott A Witteman JC Hofman A Breteler MM 1997 Dietary fat intake and the risk of incident dementia in the Rotterdam Study Ann Neurol 42 776 782 9392577
Kaltschmidt B Uherek M Volk B Baeuerle PA Kaltschmidt C 1997 Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease Proc Natl Acad Sci U S A 94 2642 2647 9122249
Kandalepas PC Sadleir KR Eimer WA Zhao J Nicholson DA Vassar R 2013 The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques Acta Neuropathologica 126 329 352 23820808
Kennedy A Martinez K Chuang CC LaPoint K McIntosh M 2009 Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications J Nutr 139 1 4 19056664
Kim JY Lee HJ Lee SJ Jung YH Yoo DY Hwang IK Seong JK Ryu JM Han HJ 2017 Palmitic Acid-BSA enhances Amyloid-beta production through GPR40-mediated dual pathways in neuronal cells: Involvement of the Akt/mTOR/HIF-1alpha and Akt/NF-kappaB pathways Sci Rep 7 4335 28659580
Koopman G Reutelingsperger C Kuijten G Keehnen R Pals S van Oers M 1994 Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis Blood 84 1415 1420 8068938
Laird FM Cai H Savonenko AV 2005 BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions The Journal of Neuroscience 25 11693 11709 16354928
Lazarov O Lee M Peterson DA Sisodia SS 2002 Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice The Journal of Neuroscience 22 9785 9793 12427834
Levin-Allerhand JA Lominska CE Smith JD 2002 Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet J Nutr Health Aging 6 315 319 12474021
Li R Lindholm K Yang LB 2004 Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer’s disease patients Proc Natl Acad Sci U S A 101 3632 3637 14978286
Liu L Chan C 2014 IPAF inflammasome is involved in interleukin-1beta production from astrocytes, induced by palmitate; implications for Alzheimer’s Disease Neurobiol Aging 35 309 321 24054992
Liu L Martin R Chan C 2013a Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases Neurobiol Aging 34 540 550 22727944
Liu L Martin R Kohler G Chan C 2013b Palmitate induces transcriptional regulation of BACE1 and presenilin by STAT3 in neurons mediated by astrocytes Exp Neurol 248 482 490 23968646
Luchsinger JA Tang MX Shea S Mayeux R 2002 Caloric intake and the risk of Alzheimer disease Arch Neurol 59 1258 1263 12164721
Maesako M Uemura K Kubota M 2012 Environmental enrichment ameliorated high-fat diet-induced Abeta deposition and memory deficit in APP transgenic mice Neurobiol Aging 33 1011e1011 1023
Maesako M Uemura M Tashiro Y 2015 High Fat Diet Enhances beta-Site Cleavage of Amyloid Precursor Protein (APP) via Promoting beta-Site APP Cleaving Enzyme 1/Adaptor Protein 2/Clathrin Complex Formation PLoS One 10 e0131199 26414661
Marwarha G 2011a Mutual upregulation of IGF-1 and leptin expression prevents their β-amyloid-induced down regulation Alzheimer’s &amp; Dementia: The Journal of the Alzheimer’s Association 7 S586
Marwarha G Berry DC Croniger CM Noy N 2014a The retinol esterifying enzyme LRAT supports cell signaling by retinol-binding protein and its receptor STRA6 FASEB J 28 26 34 24036882
Marwarha G Claycombe-Larson K Schommer J Ghribi O 2017a Maternal low-protein diet decreases brain-derived neurotrophic factor expression in the brains of the neonatal rat offspring J Nutr Biochem 45 54 66 28432877
Marwarha G Claycombe K Ghribi O 2017b Maternal low protein diet decreases leptin expression in the brains of the neonatal rat offspring The FASEB Journal 31 lb474
Marwarha G Claycombe K Lilek J Ghribi O 2017c Prenatal exposure to a maternal LP diet decreases BDNF expression in the brains of the neonatal offspring The FASEB Journal 31 644 613
Marwarha G Claycombe K Schommer J Collins D Ghribi O 2016 Palmitate-induced Endoplasmic Reticulum stress and subsequent C/EBPalpha Homologous Protein activation attenuates leptin and Insulin-like growth factor 1 expression in the brain Cell Signal 28 1789 1805 27555288
Marwarha G Dasari B Ghribi O 2012 Endoplasmic reticulum stress-induced CHOP activation mediates the down-regulation of leptin in human neuroblastoma SH-SY5Y cells treated with the oxysterol 27-hydroxycholesterol Cell Signal 24 484 492 21983012
Marwarha G Dasari B Prabhakara JP Schommer J Ghribi O 2010a beta-Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway J Neurochem 115 373 384 20670375
Marwarha G Dasari B Prasanthi JR Schommer J Ghribi O 2009 Leptin is Involved in Accumulation of Amyloid-beta and Tau Phosphorylation Induced by 27-Hydroxycholesterol in Organotypic Slices from Adult Rabbit Hippocampus Journal of Alzheimer’s Disease 19 1007 1019
Marwarha G Dasari B Prasanthi JR Schommer J Ghribi O 2010b Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices J Alzheimers Dis 19 1007 1019 20157255
Marwarha G Ghribi O 2012a Cellular model of Alzheimer’s disease--relevance to therapeutic testing Exp Neurol 233 733 739 22119424
Marwarha G Ghribi O 2012b Leptin signaling and Alzheimer’s disease Am J Neurodegener Dis 1 245 265 23383396
Marwarha G Ghribi O 2015 Does the oxysterol 27-hydroxycholesterol underlie Alzheimer’s disease-Parkinson’s disease overlap? Exp Gerontol 68 13 18 25261765
Marwarha G Ghribi O 2017a NF-kappaB - a friend, a foe, or a bystander - in the neurodegenerative cascade and pathogenesis of Alzheimer’s disease CNS Neurol Disord Drug Targets
Marwarha G Ghribi O 2017b NF-κB – a friend, a foe, or a bystander - in the neurodegenerative cascade and pathogenesis of Alzheimer’s disease CNS &amp; Neurological Disorders - Drug Targets 16 1 1
Marwarha G Ghribi O 2017c Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) – a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer’s Disease CNS &amp; Neurological Disorders - Drug Targets 16 1 16
Marwarha G Ghribi O 2017d PALMITATE-ENRICHED DIET-INDUCED ER STRESS AND CHOP ACTIVATION CAUSES TAU HYPERPHOSPHORYLATION IN THE CULTURED HUMAN NEUROBLASTOMA CELLS AND THE MOUSE BRAIN Alzheimer’s &amp; Dementia: The Journal of the Alzheimer’s Association 13 P326
Marwarha G Ghribi O Meiers C 2014b LEPTIN ATTENUATES BACE1 EXPRESSION AND AMYLOID-B GENESIS VIA THE ACTIVATION OF SIRT1 SIGNALING PATHWAY Alzheimer’s &amp; Dementia: The Journal of the Alzheimer’s Association 10 P330 P331
Marwarha G Prasanthi JR Schommer J Dasari B Ghribi O 2011a Molecular interplay between leptin, insulin-like growth factor-1, and beta-amyloid in organotypic slices from rabbit hippocampus Mol Neurodegener 6 41 21651786
Marwarha G Raza S Hammer K Ghribi O 2017d 27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer Chem Phys Lipids
Marwarha G Raza S Meiers C Ghribi O 2014c Leptin attenuates BACE1 expression and amyloid-beta genesis via the activation of SIRT1 signaling pathway Biochim Biophys Acta 1842 1587 1595 24874077
Marwarha G Raza S Prasanthi JR Ghribi O 2013 Gadd153 and NF-kappaB crosstalk regulates 27-hydroxycholesterol-induced increase in BACE1 and beta-amyloid production in human neuroblastoma SH-SY5Y cells PLoS One 8 e70773 23951005
Marwarha G Rhen T Schommer T Ghribi O 2011b The oxysterol 27-hydroxycholesterol regulates alpha-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson’s disease J Neurochem 119 1119 1136 21951066
Marwarha G Rostad S Lilek J Kleinjan M Schommer J Ghribi O 2017e Palmitate Increases beta-site AbetaPP-Cleavage Enzyme 1 Activity and Amyloid-beta Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation J Alzheimers Dis 57 907 925 28304295
Marwarha GSA 2011b Leptin expression and signaling at the confluence of neurodegenerative mechanisms in Alzheimer disease The University of North Dakota ProQuest Dissertations Publishing 3515504
Masters CL Simms G Weinman NA Multhaup G McDonald BL Beyreuther K 1985 Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc Natl Acad Sci U S A 82 4245 4249 3159021
Mattson MP Meffert MK 2006 Roles for NF-kappaB in nerve cell survival, plasticity, and disease Cell Death Differ 13 852 860 16397579
McCullough KD Martindale JL Klotz LO Aw TY Holbrook NJ 2001 Gadd153 Sensitizes Cells to Endoplasmic Reticulum Stress by Down-Regulating Bcl2 and Perturbing the Cellular Redox State Molecular and Cellular Biology 21 1249 1259 11158311
Mercurio F Zhu H Murray BW 1997 IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation Science 278 860 866 9346484
Morris MC Evans DA Bienias JL Tangney CC Bennett DA Aggarwal N Schneider J Wilson RS 2003 Dietary fats and the risk of incident Alzheimer disease Arch Neurol 60 194 200 12580703
Pandey NR Sultan K Twomey E Sparks DL 2009 Phospholipids block nuclear factor-kappa B and tau phosphorylation and inhibit amyloid-beta secretion in human neuroblastoma cells Neuroscience 164 1744 1753 19788916
Paris D Patel N Quadros A Linan M Bakshi P Ait-Ghezala G Mullan M 2007 Inhibition of Abeta production by NF-kappaB inhibitors Neuroscience letters 415 11 16 17223266
Park SH Choi HJ Yang H Do KH Kim J Lee DW Moon Y 2010 Endoplasmic reticulum stress-activated C/EBP homologous protein enhances nuclear factor-kappaB signals via repression of peroxisome proliferator-activated receptor gamma J Biol Chem 285 35330 35339 20829347
Parrott MD Greenwood CE 2007 Dietary influences on cognitive function with aging: from high-fat diets to healthful eating Ann N Y Acad Sci 1114 389 397 17986600
Patil S Melrose J Chan C 2007 Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons Eur J Neurosci 26 2131 2141 17908174
Patil S Sheng L Masserang A Chan C 2006 Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons Neurosci Lett 406 55 59 16904262
Puglielli L Tanzi RE Kovacs DM 2003 Alzheimer’s disease: the cholesterol connection Nat Neurosci 6 345 351 12658281
Rapoport SI 2001 In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling J Mol Neurosci 16 243 261 discussion 279–284 11478380
Refolo LM Malester B LaFrancois J Bryant-Thomas T Wang R Tint GS Sambamurti K Duff K Pappolla MA 2000 Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model Neurobiol Dis 7 321 331 10964604
Rostagno A Ghiso J 2009 Isolation and biochemical characterization of amyloid plaques and paired helical filaments Curr Protoc Cell Biol Chapter 3 Unit 3 33 33 33 31 33
Sannerud R Declerck I Peric A 2011 ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1 Proceedings of the National Academy of Sciences 108 E559 E568
Sheng JG Price DL Koliatsos VE 2002 Disruption of Corticocortical Connections Ameliorates Amyloid Burden in Terminal Fields in a Transgenic Model of Aβ Amyloidosis The Journal of Neuroscience 22 9794 9799 12427835
Shie FS Jin LW Cook DG Leverenz JB LeBoeuf RC 2002 Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice Neuroreport 13 455 459 11930160
Snow WM Albensi BC 2016 Neuronal Gene Targets of NF-kappaB and Their Dysregulation in Alzheimer’s Disease Front Mol Neurosci 9 118 27881951
Sokolow S Luu SH Nandy K Miller CA Vinters HV Poon WW Gylys KH 2012 Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer’s disease cortex Neurobiology of Disease 45 381 387 21914482
Sparks DL Scheff SW Hunsaker JC 3rd Liu H Landers T Gross DR 1994 Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol Exp Neurol 126 88 94 8157129
Srinivasan M Lahiri DK 2015 Significance of NF-kappaB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer’s disease and multiple sclerosis Expert Opin Ther Targets 19 471 487 25652642
Thinakaran G Koo EH 2008 Amyloid Precursor Protein Trafficking, Processing, and Function Journal of Biological Chemistry 283 29615 29619 18650430
Thirumangalakudi L Prakasam A Zhang R Bimonte-Nelson H Sambamurti K Kindy MS Bhat NR 2008 High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice J Neurochem 106 475 485 18410513
Tomita S Fujita T Kirino Y Suzuki T 2000 PDZ domain-dependent suppression of NF-kappaB/p65-induced Abeta42 production by a neuron-specific X11-like protein The Journal of biological chemistry 275 13056 13060 10777610
Van Beek M Oravecz-Wilson KI Delekta PC 2012 Bcl10 links saturated fat overnutrition with hepatocellular NF-kB activation and insulin resistance Cell Rep 1 444 452 22708078
Vandal M White PJ Tremblay C 2014 Insulin reverses the high-fat diet-induced increase in brain Abeta and improves memory in an animal model of Alzheimer disease Diabetes 63 4291 4301 25008180
Vassar R Bennett BD Babu-Khan S 1999 Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 735 741 10531052
Vermes I Haanen C Steffens-Nakken H Reutellingsperger C 1995 A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V Journal of Immunological Methods 184 39 51 7622868
Wang R Chen S Liu Y Diao S Xue Y You X Park EA Liao FF 2015 All-trans-retinoic acid reduces BACE1 expression under inflammatory conditions via modulation of nuclear factor kappaB (NFkappaB) signaling J Biol Chem 290 22532 22542 26240147
Wang R Li JJ Diao S 2013 Metabolic stress modulates Alzheimer’s beta-secretase gene transcription via SIRT1-PPARgamma-PGC-1 in neurons Cell Metab 17 685 694 23663737
Wang XZ Lawson B Brewer JW 1996 Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153) Mol Cell Biol 16 4273 4280 8754828
Willy JA Young SK Stevens JL Masuoka HC Wek RC 2015 CHOP links endoplasmic reticulum stress to NF-kappaB activation in the pathogenesis of nonalcoholic steatohepatitis Mol Biol Cell 26 2190 2204 25904325
Winocur G Greenwood CE 1999 The effects of high fat diets and environmental influences on cognitive performance in rats Behav Brain Res 101 153 161 10372571
Yan R Vassar R 2014 Targeting the β secretase BACE1 for Alzheimer’s disease therapy Lancet neurology 13 319 329 24556009
Yang LB Lindholm K Yan R 2003 Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease Nat Med 9 3 4 12514700
Zhang X Song W 2013 The role of APP and BACE1 trafficking in APP processing and amyloid-β generation Alzheimer’s Research &amp; Therapy 5 46
Zhao J Fu Y Yasvoina M 2007 β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer’s Disease Pathogenesis The Journal of Neuroscience 27 3639 3649 17409228
Zinszner H Kuroda M Wang X Batchvarova N Lightfoot RT Remotti H Stevens JL Ron D 1998 CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum Genes Dev 12 982 995 9531536
